Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation.

作者信息

Ettenger R, Cohen A, Nast C, Moulton L, Marik J, Gales B

机构信息

Division of Pediatric Nephrology, UCLA Children's Hospital 90095-1752, USA.

出版信息

Transplant Proc. 1997 Feb-Mar;29(1-2):340-1. doi: 10.1016/s0041-1345(96)00296-5.

DOI:10.1016/s0041-1345(96)00296-5

PMID:9123030

Abstract

摘要

相似文献

Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation.

Transplant Proc. 1997 Feb-Mar;29(1-2):340-1. doi: 10.1016/s0041-1345(96)00296-5.

Triple therapy with mycophenolate mofetil versus azathioprine.

Transplant Proc. 1999 Feb-Mar;31(1-2):1144-6. doi: 10.1016/s0041-1345(98)01939-3.

Triple therapy with mycophenolate mofetil, cyclosporine, and prednisone in renal transplantation.

Transplant Proc. 1999 Sep;31(6):2261-2. doi: 10.1016/s0041-1345(99)00329-2.

Safety and efficacy of mycophenolate mofetil for prophylaxis in Asian renal transplant recipients.

Transplant Proc. 2000 Nov;32(7):1757-8. doi: 10.1016/s0041-1345(00)01388-9.

Mycophenolate mofetil in living donor renal allograft recipients.

Transplant Proc. 1999 Feb-Mar;31(1-2):1133. doi: 10.1016/s0041-1345(98)01934-4.

Mycofenolate mofetil-cyclosporine immunosuppression of kidney transplantation recipients with two different corticosteroid doses.

Transplant Proc. 2001 May;33(3):2302-3. doi: 10.1016/s0041-1345(01)01999-6.

Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients.

Transplant Proc. 1999 Sep;31(6):2259-60. doi: 10.1016/s0041-1345(99)00328-0.

Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation.

Transplant Proc. 1998 Dec;30(8):4096-7. doi: 10.1016/s0041-1345(98)01355-4.

A prospective randomised study of CSA monotherapy versus CSA plus mycophenolate mofetil in cadaveric renal transplant recipients.

Transplant Proc. 1998 Dec;30(8):4098. doi: 10.1016/s0041-1345(98)01356-6.

Mycophenolate mofetil, ATG, and cyclosporine in the induction treatment of renal transplant recipients minimizes the incidence of acute rejection episodes.

Transplant Proc. 1998 Aug;30(5):2226-7. doi: 10.1016/s0041-1345(98)00598-3.

引用本文的文献

Pediatric kidney transplantation: a historical review.

Pediatr Res. 2017 Jan;81(1-2):259-264. doi: 10.1038/pr.2016.207. Epub 2016 Oct 12.

The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy.

Pediatr Nephrol. 2017 Jan;32(1):21-29. doi: 10.1007/s00467-016-3352-2. Epub 2016 Feb 26.

Pharmacokinetics and pharmacodynamics of mycophenolic acid and their relation to response to therapy of childhood-onset systemic lupus erythematosus.

Semin Arthritis Rheum. 2011 Feb;40(4):307-13. doi: 10.1016/j.semarthrit.2010.05.007. Epub 2010 Jul 23.

Inosine monophosphate dehydrogenase (IMPDH) activity as a pharmacodynamic biomarker of mycophenolic acid effects in pediatric kidney transplant recipients.

J Clin Pharmacol. 2011 Mar;51(3):309-20. doi: 10.1177/0091270010368542. Epub 2010 Apr 23.

Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome.

Ann Saudi Med. 2005 Sep-Oct;25(5):380-4. doi: 10.5144/0256-4947.2005.380.

Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary?

Clin Pharmacokinet. 2002;41(5):319-27. doi: 10.2165/00003088-200241050-00001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验